Hi-Tech Pharmacal Co Inc (NASDAQ:HITK)
| 33.70 Data as of May 24 |  -0.68 / -1.98%Today’s Change | 27.35 Today|||52-Week Range 38.17 | -3.66% Year-to-Date |
Latest HITK News | Press Releases
| HITK Makes Bullish Cross Above Critical Moving Average May 22 / TheStreet.com | HITK January 2014 Options Begin Trading May 20 / TheStreet.com |
Today’s Trading
| Previous close | 34.38 |
| Today’s open | 34.13 |
| Day’s range | 33.57 - 34.40 |
| Volume | 50,570 |
| Average volume (3 months) | 61,289 |
| Market cap | $457.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +12.54% |
| Earnings growth (this year) | -39.42% |
| Earnings growth (next 5 years) | -11.40% |
| Revenue growth (last year) | +20.52% |
| P/E ratio | 15.0 |
| Price/Sales | 1.82 |
| Price/Book | 1.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DVAXDynavax Technologies... | +0.01 | +0.40% |
| SCRSimcere Pharmaceutic... | +0.03 | +0.32% |
| NDZNordion Inc | -0.22 | -2.74% |
| AVNRAvanir Pharmaceutica... | +0.01 | +0.29% |
Data as of 4:06pm ET, 05/24/2013
Financials
| Next reporting date | July 16, 2013 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $230.0M |
| Annual profit (last year) | $48.4M |
| Net profit margin | 21.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President, CEO, Secretary & Treasurer David S. Seltzer |
Vice President- Operations Eyal Mares |
Corporate headquarters Amityville, New York |
Forecasts
